MLA

Transition At Teva - Blockbuster Drug Copaxone to Lose Patent Protection In 2014. MarketLine, a Progressive Digital Media business, 0.

APA

(0). Transition at Teva - Blockbuster Drug Copaxone to Lose Patent Protection in 2014. MarketLine, a Progressive Digital Media business.

Chicago

Transition At Teva - Blockbuster Drug Copaxone to Lose Patent Protection In 2014. : MarketLine, a Progressive Digital Media business, 0.